Brazil CFM Approves PRP for Knee Osteoarthritis, Reversing 2015 Restriction

Brazil's Federal Council of Medicine (CFM) has authorized the complementary use of platelet-rich plasma (PRP) for knee osteoarthritis and three other osteomuscular conditions, reversing its 2015 stance that limited PRP to research protocols. The regulatory shift expands clinical access but does not specify reimbursement or coverage details. This matters as it sets a national precedent for PRP adoption in Brazil, potentially influencing regional medical practice and health policy.